Skip to main content

Navigation group

Type at least 3 characters

5 articles

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 21 Feb 2025

Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes

in Neurological Drugs

Joseph S. Anderson
Jill L. Silverman
Alyse L. Lodigiani
Camilla M. Barbaduomo
Julie R. Beegle

Frontiers in Drug Discovery

doi 10.3389/fddsv.2025.1545391

243 views

Editorial

Published on 25 Mar 2024

Editorial: The boulder peptide symposium 2021 scientific update

in Neurological Drugs

Yvonne Angell
John Mayer
Rebecca Nofsinger
Waleed Danho

Frontiers in Drug Discovery

doi 10.3389/fddsv.2024.1394489

700 views

Brief Research Report

Published on 21 Feb 2023

Numaswitch, a biochemical platform for the efficient production of disulfide-rich pepteins

in Neurological Drugs

Bach-Ngan Nguyen
Florian Tieves
Florian G. Neusius
Hansjörg Götzke
Lutz Schmitt
Christian Schwarz

Numaswitch, a biochemical platform for the efficient production of disulfide-rich pepteins

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1082058

2,851 views
1 citation

Original Research

Published on 14 Jan 2022

Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism

in Neurological Drugs

Christopher R. Apostol
Kelsey Bernard
Parthasaradhireddy Tanguturi
Gabriella Molnar
Mitchell J. Bartlett
Lajos Szabò
Chenxi Liu
J. Bryce Ortiz
Maha Saber
Katherine R. Giordano

Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism

Frontiers in Drug Discovery

doi 10.3389/fddsv.2021.818003

6,192 views
13 citations

Review

Published on 11 Nov 2021

Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient

in Neurological Drugs

Nuno Jorge Lamas
Laurent Roybon

Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient

Frontiers in Drug Discovery

doi 10.3389/fddsv.2021.773424

5,746 views
13 citations